baxter bax start clinical trial drug baxter travenol laboratory hyland therapeutic unit start human clinical trial genetically engineer factor viii clot agent miss blood hemophiliac unlike factor viii concentrate currently genetically engineer factor viii limit availability human plasma completely free bloodborne virus include aid form hepatitis baxter baxter final clinical trial highly purify form factor viii derive human plasma produce use advance process incorporate monoclonal antibody purification genetics institute publicly hold biotechnology company baxter shareholder supply protein human clinical test substantial portion ongoing production requirement 
